If you're currently on Medicare or will be soon, here are five myths worth debunking to help you understand the program ...
The threat of virtually no payment rate increases next year for Medicare Advantage plans sent managed care organizations, and ...
Profits will start to tick up after reaching trough levels. Washington will play nice. M&A and AI adoption will accelerate.
Retirees on Medicare will soon be unable to access this incredibly popular service.
The Trump administration kicked off another round of Medicare drug price negotiations, while Kaiser Permanente agrees to pay ...
The Trump administration on Tuesday announced the next round of prescription drugs up for Medicare price negotiations.
CMS's proposed 0.09% Medicare Advantage rate hike for 2027 triggered a sharp sell-off across US health insurers, signaling ...
CMS's third drug negotiation cycle under the IRA targets high-expenditure drugs, impacting Medicare Part B and D spending. The list includes drugs for cancer, HIV, and diabetes, with significant ...
The Centers for Medicare & Medicaid Services yesterday announced 15 drugs under Medicare Parts D and B selected for the third round of price negotiations. Negotiations will occur this year and any ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results